High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases

Cancer

Volumn 95, Issue 5, 2002, Pages 1076-1084

  Tauchmanov̀, Libuse ^a   Selleri, Carmine ^a   De Rosa, Gennaro ^a   Pagano, Loredana ^a   Orio, Francesco ^a   Lombardi, Gaetano ^a   Rotoli, Bruno ^a   Colao, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Adrenal insufficiency; Allogeneic bone marrow transplantation; Chronic GVHD; Chronic thyroiditis; Gonadal function; Low T3 syndrome; Ovarian failure; Stem cell transplantation

Indexed keywords

ADOLESCENT; ADRENAL INSUFFICIENCY; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; ENDOCRINE DISEASE; FEMALE; GONAD FUNCTION; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVARY INSUFFICIENCY; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; THYROIDITIS; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; ENDOCRINE SYSTEM DISEASES; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREVALENCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036721205     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10773     Document Type: Article

References (31)

1. Malignant neoplasms in long-term survivors of bone marrow transplantation
2. Effects of allogenic bone marrow transplantation on recipient bone mineral density: A prospective study
3. Endocrine complications of bone marrow transplantation in children
4. Thyroid function after bone marrow transplantation: Possible association between immune-mediated thyreotoxicosis and hypothyroidism
5. Short- and long-term follow-up of thyroid dysfunction after allogenic bone marrow transplantation without the use of preparative total body irradiation
6. Gynecological abnormalities following allogenic bone marrow transplantation
7. Growth and endocrine function after bone marrow transplantation
8. The role of cytokines in graft-versus-host reaction and disease
9. Chronic graft-versus-host-disease and other late complications of bone marrow transplantation
10. Endocrine function after bone marrow transplantation for thalassemia
11. Clinical manifestation of graft versus host disease in human recipients of marrow from HLA-matched siblings donors
12. Chronic graft-versus-host disease in man: A clinicopathologic study of 20 long term Seattle patients
13. Autoantibodies in chronic GVHD: High prevalence of antinuclear antibodies
14. Antimitochondrial antibodies in patients with chronic graft-versus-host disease
15. European multicenter study of chronic graft-versus-host disease
16. Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation
17. Ovarian function after autologous bone marrow transplantation
18. Ovarian function following marrow transplantation for aplastic anemia or leukemia
19. Antineoplastic agents
20. Cyclophosphamide-induced ovarian failure
21. Late complications of transplants in adults
22. Cyclic sex hormone replacement therapy in women undergoing allogenic bone marrow transplantation: Aims and results
23. The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function
24. The somatomedin hypothesis: 2001
25. Allogenic bone marrow transplantation in adults: Endocrine sequelae after 1-6 years
26. Late complications of transplants. Endocrinological complications
27. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation
28. Growth and endocrine function in children with acute myeloid leukemia after bone marrow transplantation using busulphan/cyclophosphamide
29. Opposite effects of corticosteroids on serum concentration of 3,3′,5 triiodothyronine (reverse T3) and 3,3′,5 triiodothyronine (T3)
30. Evidence for an inhibitor of extrathyroidal conversion of thyroxin to 3,5,3′ triiodothyronine in sera of patients with nonthyroidal illness
31. Solid cancers after bone marrow transplantation